QCM
VIR icon

Quantinno Capital Management’s Vir Biotechnology VIR Stock Holding History

Quantinno Capital Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$860K Buy
95,927
+56,655
+144% +$451K ﹤0.01% 2279
2025
Q4 		$237K Buy
39,272
+16,391
+72% +$97.6K ﹤0.01% 2971
2025
Q3 		$131K Buy
22,881
+44
+0.2% +$225 ﹤0.01% 2855
2025
Q2 		$115K Buy
22,837
+4,129
+22% +$22.1K ﹤0.01% 2483
2025
Q1 		$121K Buy
+18,708
New +$166K ﹤0.01% 1985
2024
Q3 		– Sell
-10,828
Closed -$96.4K – 1496
2024
Q2 		$96.4K Buy
+10,828
New +$104K ﹤0.01% 1297

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Quantinno Capital Management's VIR Position: Q1 2026 in Review

Quantinno Capital Management increased its Vir Biotechnology (VIR) stake by 144% in Q1 2026, buying an estimated $451K and bringing the position to 95,927 shares worth $860K. The position accounts for ﹤0.01% of the portfolio, ranked #2279.

Quantinno Capital Management first reported a position in VIR in Q2 2024 and has held it in 6 quarters since. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Quantinno Capital Management held 95,927 shares of Vir Biotechnology worth $860K as of Q1 2026.
  • Quantinno Capital Management bought 56,655 Vir Biotechnology shares in Q1 2026, an estimated $451K.
  • Vir Biotechnology made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #2279 holding.
  • Quantinno Capital Management first reported a position in Vir Biotechnology in Q2 2024 and has held it in 6 quarters since.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.